The mutagenic and toxic effects of bleomycin and trifluoperazine in Drosophila melanogaster

Drug and Chemical Toxicology

Volumn 22, Issue 2, 1999, Pages 389-400

  Khabour, O F ^a   Sadiq, M F ^a  

^a YARMOUK UNIVERSITY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; TRIFLUOPERAZINE;

ACUTE TOXICITY; ARTICLE; DNA REPAIR; DNA STRAND BREAKAGE; DROSOPHILA MELANOGASTER; GENE DELETION; GENE INDUCTION; GENE MUTATION; MEIOSIS; MUTAGENICITY; NONHUMAN; SPERMATOGENESIS; Y CHROMOSOME LINKAGE;

DROSOPHILA MELANOGASTER; MELANOGASTER;

EID: 0032963706     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549909017842     Document Type: Article

References (34)

1. Hait, W. N., Lazo, J. S., Chen, D. L., Gallichio, V. S. and Filderman, A. E., Antitumor and toxic effects of combination chemotherapy with bleomycin and a phenothiazine anticalmodulin agent., J. Natl Cancer Inst., 80:246-250, 1988.
2. Hait, W. N., Lazo, J. S., Morris, S., Durivage, H., White, K. and Schwartz, P., Phase I trial of bleomycin and trifluoperazine in treatment of malignant diseases., Cancer Chemother. Pharmacol., 23:358-362, 1989.
3. Hait, W. N., Byrne, T. N., Piepmeier, J. and Durivage, H. J., The effect of calmodulin inhibitors with bleomycin on the treatment of patients with high grade gliomas., Cancer Res., 50:6636-6640, 1990.
4. Chafouleas, J. G., Bolton, W. E. and Means, R. A., Potentiation of bleomycin lethality by anti-calmodulin drugs: a role for calmodulin in DNA repair., Science, 224:1346-1348, 1984.
5. Lazo, J. S., Chen, E. L., Gallicchio, V. S. and Hait, W. N., Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin resistant malignant cells., Cancer Res., 46:2236-2240, 1986.
6. Zhang, H. Q., He, N. G. and Xue, S. B., Effect of bleomycin A-5 with calmodulin inhibitor on the proliferations of S-180 cells in vitro. Acta Pharmacologica Sinica, 11:470-473, 1990.
7. Hait, W. N., Gesmonde, J. F. and Lazo, J. S., Effect of anticalmodulin drug on the growth and sensitivity of C6 rat glioma-cells to bleomycin., Anticancer Res., 14: 1711-1721, 1994.
8. Vig, B. K. and Lewis, Genetic, R., Toxicology of bleomycin., Mutation Res., 55:121-145, 1978.
9. Umezawa, H. and Takita, T., The development of new bleomycins. In Hellman, K. and S. K. Carter., Fundamentals of Cancer Chemotherapy. McGraw-Hill. New York, USA, 159-166, 1987.
10. Povirk, L. F. and Austin, M. J. F., Genotoxicity of bleomycin, Mutation Res., 257: 127-143, 1991.
11. Leftrove, I. M. and Koldamora, R. P., Schedule dependent variation in human lymphocyte sensitivity to bleomycin and repair of chromosomal aberration in G2, Mutation Res., 284:198-204, 1992.
12. Darroudi, F., Farooqi, Z., Benova, D. and Nataragan, A. T., The mouse splenocyte assay, an in vivo/in vitro system for biological monitoring. Studies with X-ray, fission neutrons and bleomycin., Mutation Res., 272:237-248, 1992.
13. MacLeod, R.A.F, Voges, M., Bryant, P. E. and Drexler, H. G., Chromatid aberration dose responses and dispersal in human G2 lymphocytes treated with bleomycin: comparison with equivalent X-irradiation reveals formation of a novel class of heavily damaged cells., Mutation Res., 309:73-81, 1994.
14. Dubinina, L. G., Mutagenicity of bleomycin and cross-adaptation with alkylating-agents in Crepis capillaris., Genetika, 31:652-659, 1995.
15. Erexon, G. L., Bryant, M. F., Kwanyuen, P. and Kligerman, A. D., Bleomycin sulfate-induced micronuclei in human, rat and mouse peripheral - blood lymphocytes, Environ. Mole. Mutagen, 25:31-36, 1995.
16. Cook, W. J., Walter, L. J. and Walter, M. R., Drug binding by calmodulin: Crystal structure of calmodulin - trifluoperazine complex., Biochemistry, 33:15259-15265, 1994.
17. Smith, P. J., Mircheva, J. J. and Bleehen, N. M., Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells: II. DNA damage, repair and chromatin changes, Brit. J. Cancer, 53:105-115, 1986.
18. Smith, P. J., Mircheva, J. J. and Bleehen, N. M., Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine, ACTA Physiol. et Pharmacol. Blugarica, 13:41-45, 1987.
19. Sadiq, M. F. and Khabour, O. F., Induction of mosaic sex-linked recessive lethals in the different germ cell stages of Drosophila melanogaster by bleomycin, Mutation Res., 397:279-285, 1998.
20. Traut, H., Mutagenic effects of bleomycin in Drosophila melanogaster, Environ. Mutagen., 2:89-96, 1980.
21. Vogel, E. W. and Zijlstra, J. A., Somatic cell mutagenicity in Drosophila melanogaster in comparison with genetic damage in early germ cell stages, Mutation Res., 180:189-200, 1987.
22. Mason, J. M., Aaron, C. S., Lee, W. R., Smith, P. D., Thakar, A., Valencia, R., Woodruff, R. C., Wurgler, F. E. and Zimmering, S., A guide for performing germ cell mutagenesis assays using Drosophila melanogaster, Mutation Res., 189:93-102, 1987.
23. Lee, W. R., Abrahamson, S., Valencia, R., Halle, E. S., von Wurgler, F. E. and Zimmering, S., The sex-linked recessive lethal test for mutagenesis in Drosophila melanogaster, Mutation Res., 123:183-279, 1983.
24. Sadiq, M. and Mathew, C., Production of mosaic lethals in different germ cell stages of Drosophila by N-methyl-N-nitro-N-nitroso guanidine, Mutation Res., 45:31-39, 1977.
25. Abrahamson, S., Wurgler, F. E., Jongh, C. D. and Meyer, H. U., How many loci on the chromosome of Drosophila melanogaster can mutate to recessive lethals? Environ. Mutagen., 2:447-453, 1980.
26. Mathew, C., The nature of delayed mutation after treatment with chloroethyl methane sulphonate and other alkylating agents, Mutation Res., 1:163-172, 1964.
27. Kastenbaum, M. A. and Bowman, K. O., Tables for determining the statistical significance of mutation frequencies, Mutation Res., 9:527-549, 1970.
28. Edwards, N. J., Taylor, A. N. R. and Flude, E. J., Bleomycin induced inhibition of DNA synthesis in ataxia-telangiectasia cell lines., Biochem. Biophys. Res. Commun., 102:610-626, 1981.
29. Bukeo, T., The effects of calmodulin inhibitors (W-7, trifluoperazine) in cultured glioma cells, Okayama Igakkai Zasshi, 102:465-484, 1990.
30. Osborn, M. and Weber, K., Damaged cellular function by trifluoperazine, a calmodulin specific drug, Exp. Cell. Res., 130:484-489, 1980.
31. Jose, J. G., Photomutagenesis by chlorinated phenothiazine tranquilizers, Proc. Natl. Acad. Sci, USA, 76:469-472, 1979.
32. Suryanarayana, A., Rita, P. and Reddy, P. P., In vitro effect of trifluorperazine on human lymphocytes, JPN. J. Exp. Med., 57:277-279, 1987.
33. Auerbach, C., The chemical production of mutations, Science, 158:1141-1147, 1967.
34. Bennett, R. A. O., Swerdlow, P. S. and Povirk, L. F., Spontaneous cleavage of bleomycin-induced abasic sites in chromatin and their mutagenicity in mammalian shuttle vectors, Biochemistry, 32:3188-3195, 1993.